HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibody and antigen (Recombinant protein)
Diagnostic hepatitis C (HCV) antibodies (anti-hepatitis C, anti-HCV) and antigens (recombinant hepatitis C (HCV) NS3-NS4-NS5 fusion protein) for Infectious disease Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-IVD-P007-Tg001-Ag01 | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein | 3090 |
GMP-IVD-P007-Tg001-Ab01 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) | 3090 |
GMP-IVD-P007-Tg001-Ab02 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) | 3090 |
GMP-IVD-P007-Tg001-Ab03 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) | 3090 |
GMP-IVD-P007-Tg001-Ab04 | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) | 3090 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-IVD-P007-Tg001-Ag01 |
Product Name | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein |
Pathogen | hepatitis C virus |
Target/Biomarker | hepatitis C virus (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | His |
Products description | Recombinant human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P007-Tg001-Ab01, GMP-IVD-P007-Tg001-Ab02 |
Product Name | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) |
Pathogen | hepatitis C virus |
Target/Biomarker | hepatitis C virus (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Human HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | mFc |
Products description | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-IVD-P007-Tg001-Ab03, GMP-IVD-P007-Tg001-Ab04 |
Product Name | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) |
Pathogen | hepatitis C virus |
Target/Biomarker | hepatitis C virus (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Human HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other HCV core antigen (Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag)) antibodies in Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) level test of Infectious disease (Hepatitis C) and related syndrome evaluation. |
Tag | hFc |
Products description | Anti-human hepatitis C virus (HCV) Recombinant HCV NS3-NS4-NS5 fusion Protein (His Tag) human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. |
Formulation | Supplied as a 0.2 μM filtered solution of PBS,PH7.4. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Hepatitis C (HCV) is an infectious disease caused by the hepatitis C virus (HCV) that primarily affects the liver. During the initial infection people often have mild or no symptoms. Occasionally a fever, dark urine, abdominal pain, and yellow tinged skin occurs. It often leads to liver disease and occasionally cirrhosis. In some cases, those with cirrhosis will develop serious complications such as liver failure, liver cancer, or dilated blood vessels in the esophagus and stomach.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments